Evidence map›Paper›PMID 39012154›Full record

ArticlemSystems2024

Gut microbiome diversity within

Laura Salazar-Jaramillo, Jacobo de la Cuesta-Zuluaga, Luis A Chica, María Cadavid, Ruth E Ley, Alejandro Reyes, Juan S Escobar

Abstract read
In one paragraph

Article in mSystems, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Dietary Supplementation withAnimals : an open access journal from MDPI · 2026
    Article
  5. Article
  6. Optimized Extraction of Soluble Dietary Fiber fromFoods (Basel, Switzerland) · 2026
    Article
  7. Article
  8. Characterization of the gut microbiome of wildFrontiers in microbiomes · 2026
    Article
  9. Article
  10. Article
  11. Gut Microbiota-Mediated Mechanisms of Traditional Chinese Medicine in Obesity Management.Diabetes, metabolic syndrome and obesity : targets and therapy · 2026
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Using Gut Microbiota Modulation as a Precision Strategy Against Obesity.International journal of molecular sciences · 2025
    Review
  18. Gut-Adipose Tissue Axis and Metabolic Health.Current issues in molecular biology · 2025
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Laura Salazar-JaramilloVidarium-Nutrition, Health and Wellness Research Center, Grupo Empresarial Nutresa, Medellin, Colombia.
Jacobo de la Cuesta-ZuluagaDepartment of Microbiome Science, Max Planck Institute for Biology, Tübingen, Germany.ORCID 0000-0002-7369-992X
Luis A ChicaDepartment of Biological Sciences, Max Planck Tandem Group in Computational Biology, Research Group in Computational Biology and Microbial Ecology (BCEM), Universidad de los Andes, Bogota, Colombia.
María CadavidVidarium-Nutrition, Health and Wellness Research Center, Grupo Empresarial Nutresa, Medellin, Colombia.
Ruth E LeyDepartment of Microbiome Science, Max Planck Institute for Biology, Tübingen, Germany.ORCID 0000-0002-9087-1672
Alejandro ReyesDepartment of Biological Sciences, Max Planck Tandem Group in Computational Biology, Research Group in Computational Biology and Microbial Ecology (BCEM), Universidad de los Andes, Bogota, Colombia.ORCID 0000-0003-2907-3265
Juan S EscobarVidarium-Nutrition, Health and Wellness Research Center, Grupo Empresarial Nutresa, Medellin, Colombia.ORCID 0000-0001-7304-917X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

IMPORTANCE: The gut microbiota is diverse across various taxonomic levels. At the intra-species level, it comprises multiple strains, some of which may be host-specific. However, our understanding of fine-grained diversity has been hindered by the use of the conserved 16S rRNA gene. While shotgun metagenomics offers higher resolution, it remains costly, may fail to identify specific microbes in complex samples, and requires extensive computational resources and expertise. To address this, we employed a simple and cost-effective analysis of alternative genetic markers to explore diversity within

Indexed as

Gastrointestinal MicrobiomeObesityAdultBody Mass IndexCross-Sectional StudiesFemaleHumansMaleMetagenomicsMiddle AgedRNA, Ribosomal, 16SRNA, Ribosomal, 16S16S rRNAAcutalibacteraceaeBMIdnaKgyrBLachnospiraceaemetagenomicsOscillospiraceaeRuminococcaceaeVescimonas

Identifiers

PMID39012154
PMCPMC11334427

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.